Lisata Therapeutics, Inc. (LSTA)
1.21
-0.07
(-5.47%)
USD |
NASDAQ |
Nov 13, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 19:59
Lisata Therapeutics Price : 1.21 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 1.25 | 1.26 | 1.20 | 1.21 | 104863.0 |
| Nov 12, 2026 | 1.21 | 1.30 | 1.15 | 1.28 | 119689.0 |
| Nov 11, 2026 | 1.03 | 1.43 | 1.03 | 1.20 | 1.061M |
| Nov 10, 2026 | 1.09 | 1.09 | 1.01 | 1.02 | 20347.00 |
| Nov 09, 2026 | 1.06 | 1.21 | 0.985 | 1.12 | 292876.0 |
| Nov 06, 2026 | 1.02 | 1.06 | 0.99 | 1.03 | 15114.00 |
| Nov 05, 2026 | 1.06 | 1.069 | 0.9915 | 0.9915 | 63267.00 |
| Nov 04, 2026 | 1.063 | 1.105 | 1.06 | 1.06 | 13622.00 |
| Nov 03, 2026 | 1.01 | 1.09 | 1.01 | 1.09 | 29513.00 |
| Nov 02, 2026 | 1.08 | 1.148 | 1.00 | 1.01 | 97149.00 |
| Oct 30, 2026 | 0.9901 | 1.090 | 0.9901 | 1.02 | 60778.00 |
| Oct 29, 2026 | 1.04 | 1.12 | 0.99 | 1.01 | 27853.00 |
| Oct 28, 2026 | 1.01 | 1.12 | 1.01 | 1.06 | 75392.00 |
| Oct 27, 2026 | 1.04 | 1.04 | 1.01 | 1.02 | 40773.00 |
| Oct 26, 2026 | 0.98 | 1.06 | 0.9612 | 1.06 | 60318.00 |
| Oct 23, 2026 | 1.00 | 1.01 | 0.97 | 0.9959 | 45557.00 |
| Oct 22, 2026 | 1.06 | 1.06 | 1.00 | 1.005 | 27668.00 |
| Oct 21, 2026 | 1.05 | 1.070 | 1.01 | 1.05 | 45570.00 |
| Oct 20, 2026 | 1.00 | 1.08 | 0.996 | 1.04 | 113743.0 |
| Oct 19, 2026 | 1.03 | 1.04 | 0.9604 | 1.00 | 96293.00 |
| Oct 16, 2026 | 1.04 | 1.07 | 1.02 | 1.03 | 57127.00 |
| Oct 15, 2026 | 1.05 | 1.07 | 1.00 | 1.07 | 23166.00 |
| Oct 14, 2026 | 1.00 | 1.07 | 0.996 | 1.02 | 80257.00 |
| Oct 13, 2026 | 1.10 | 1.150 | 0.99 | 1.08 | 146856.0 |
| Oct 12, 2026 | 1.04 | 1.06 | 0.98 | 1.05 | 166669.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.75 |
| Alnylam Pharmaceuticals, Inc. | 165.04 |
| Anika Therapeutics, Inc. | 13.40 |
| Savara, Inc. | 4.64 |
| Arrowhead Pharmaceuticals, Inc. | 47.78 |
Price Related Metrics
| PS Ratio | 109.66 |
| Price to Book Value | 1.710 |
| Earnings Yield | -155.7% |
| Market Cap | 11.03M |